Medical Pharmacology Chapter 16:  Pharmacology of Antipsychotics Drugs

Section Table of Contents

Site Table of Contents

Previous Page

Next Page

Section Table of Contents

Site Table of Contents

Previous Page

 Next Page
References

  1. Delay J, Deniker P. Le traitement des psychoses par une méthode neurolytique dérivée de l'hibernothérapie. CR Congr Méd Alién Neurol (France). 1952;50:497–502. [No PubMed entry — historical conference proceeding]

  2. Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh). 1963;20:140–144. Click for article.

  3. Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976;192(4238):481–483.  Click for article.

  4. Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 1976;261(5562):717–719.  Click for article.

  5. NIMH Psychopharmacology Service Center Collaborative Study Group. Phenothiazine treatment in acute schizophrenia. Arch Gen Psychiatry. 1964;10(3):246–261.  Click for article.

  6. Davis JM. Overview: maintenance therapy in psychiatry. I. Schizophrenia. Am J Psychiatry. 1975;132(12):1237–1245.  Click for article.

  7. Lieberman JA, Stroup TS, McEvoy JP, et al.; CATIE Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–1223.  Click for article

  8. Leucht S, Tardy M, Komossa K, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379(9831):2063–2071. Click for article.

  9. Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry. 1982;39(4):486–487.  Click for article (additonal information)

  10. Kane JM, Woerner M, Lieberman J. Tardive dyskinesia: prevalence, incidence, and risk factors. J Clin Psychopharmacol. 1988;8(4 Suppl):52S–56S.  Click for article.

  11. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77(1):185–202.  Click for article

  12. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;212:11–19. Click for article

  13. American Psychiatric Association Practice Guideline Writing Group (Keepers GA, Chair). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia [executive summary]. Am J Psychiatry. 2020;177(9):868–872 [full guideline: Washington DC: APA, 2021]. Click for article

  14. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373(9657):31–41.  Click for article

  15. Glazer WM, Kane JM. Depot neuroleptic therapy: an underutilized treatment option. J Clin Psychiatry. 1992;53(12):426–433.  Click for article

DISCLAIMER 

This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.